 This is a prospective, randomized, double-blind, placebo-controlled single center clinical trial designed to evaluate the effects of intravenous NAC on patients with acute coronary syndromes ACSundergoing coronary angiography andor percutaneous coronary intervention PCI. The medication Acetadote is provided by Cumberland Pharmaceuticals Inc 